Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Establishment and characterization of an optimized mouse model of multiple sclerosis-induced neuropathic pain using behavioral, pharmacologic, histologic and immunohistochemical methods.
Editorial comment.
Measurement and treatment of imbalance and fall risk in multiple sclerosis using the international classification of functioning, disability and health model.
Sphingosine-1-phosphate in chronic intestinal inflammation and cancer.
Intensive care unit admission in multiple sclerosis: Increased incidence and increased mortality.
Automatic multiple sclerosis lesion detection in brain MRI by FLAIR thresholding.
[Neurodegeneration in multiple sclerosis and the neuroprotective effect of glatiramer acetate: a literature review].
Anti-MOG antibodies are present in a subgroup of patients with a neuromyelitis optica phenotype.
An RCT to treat learning impairment in multiple sclerosis: The MEMREHAB trial.
Effects of exercise training on fatigue in multiple sclerosis: a meta-analysis.
Type I and III interferons enhance IL-10 receptor expression on human monocytes and macrophages, resulting in IL-10-mediated suppression of TLR-induced IL-12p70 production.
Tribute to John F. Kurtzke, MD, FACP, FAAN: 1926-2015.
Primary Cutaneous Cryptococcus in a Patient With Multiple Sclerosis Treated With Fingolimod.
Association Between Physical Fitness and Cognitive Function in Multiple Sclerosis: Does Disability Status Matter?
Copy number variation in pediatric multiple sclerosis.
Optic Nerve and its Arterial-Venous Vascularization: An Ultrasonologic Study in Multiple Sclerosis Patients and Healthy Controls.
The multiple sclerosis visual pathway cohort: understanding neurodegeneration in MS.
Reply to Article: High inbreeding in the Faroe Islands does not appear to constitute a risk factor for multiple sclerosis.
Platelets and neurovascular inflammation.
Perivascular spaces in MS patients at 7 Tesla MRI: A marker of neurodegeneration?
Tetracyclines and neuromuscular disorders.
Long-Term Data of Efficacy, Safety and Tolerability in a Real Life Setting of THC/CBD Oromucosal Spray-Treated Multiple Sclerosis Patients.
[Autonomic nervous system alteration in multiple sclerosis patients with urinary symptoms. Clinical, urodynamic and cardiovascular study].
Distinction between MOG antibody-positive and AQP4 antibody-positive NMO spectrum disorders.
Self-management for people with multiple sclerosis: report from the first international consensus conference, november 15, 2010.

Pages